NMN supplement study for healthy middle-aged and older adults
This study tests if nicotinamide mononucleotide (NMN), a natural supplement, can help middle-aged and older adults stay healthy. It aims to see if NMN can slow aging-related changes in healthy people between 40-70 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in Quzhou or have lived there for over 10 years.
- You are between 40-50 or 60-70 years old and in good health.
- You do not have serious health problems like cancer, heart disease, kidney disease, or dementia.
- You are not taking certain medications (like chemotherapy drugs or blood thinners).
- You are not pregnant or breastfeeding.
- You do not have a BMI over 30 or a history of alcohol or drug abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a supplement called nicotinamide mononucleotide (NMN) can help healthy adults aged 60 to 80 improve their exercise tolerance. You'll take the supplement and do supervised cycling sessions to see if it boosts your stamina.
This trial studies whether taking an NAD supplement can support brain blood vessel health as people age. Participants will be tested for brain and health changes and may help researchers understand how to keep the brain’s blood vessels healthier over time.
This trial tests whether a daily supplement called nicotinamide riboside can help older adults who feel weak or frail to get stronger and more energetic. It lasts for several months and involves simple tests like a walking test and memory checks.
This trial tests whether nicotinamide riboside can improve elevated blood pressure and blood vessel stiffness in middle-aged and older adults. You may be randomly assigned to take the study medicine or not, and the team will check your heart/blood vessel measurements over time.
This trial tests whether a sustained-release nicotinamide mononucleotide (NMN) supplement can improve immune aging and metabolism in people aged 50-70 who are overweight or have fatty liver, pre-diabetes, or mild type 2 diabetes.
This study looks at how the body uses NAD+ precursors (nutrients that help cells produce energy) after taking them by mouth. Healthy volunteers will help researchers understand how these supplements are processed, which may guide future treatments for aging and disease.
Hear when a new Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.